BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6601490)

  • 1. The cell population of cutaneous B-cell lymphomas.
    Willemze R; de Graaff-Reitsma CB; van Vloten WA; Meijer CJ
    Br J Dermatol; 1983 Apr; 108(4):395-409. PubMed ID: 6601490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous B-cell lymphoma.
    Burg G; Kaudewitz P; Klepzig K; Przybilla B; Braun-Falco O
    Dermatol Clin; 1985 Oct; 3(4):689-704. PubMed ID: 3916175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germinal center cell-derived lymphomas of the skin.
    Kerl H; Kresbach H
    J Dermatol Surg Oncol; 1984 Apr; 10(4):291-5. PubMed ID: 6608541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
    Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of B-cell non-Hodgkin's lymphomas. A study using a panel of monoclonal and heterologous antibodies.
    van der Valk P; Jansen J; Daha MR; Meijer CJ
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):289-305. PubMed ID: 6195805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas.
    Williamson JM; Grigor I; Smith ME; Holgate CS; Quirke P; Bird CC; Alison DL; Child JA
    J Pathol; 1986 Sep; 150(1):51-9. PubMed ID: 3491205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies.
    Ralfkiaer E; Hou-Jensen K; Mason DY; Stein H; Wantzin GL; Thomsen K
    Adv Exp Med Biol; 1985; 186():1033-41. PubMed ID: 3876696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL; Nadler LM; Bhan AK
    Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.
    Vonderheid EC; Tan E; Sobel EL; Schwab E; Micaily B; Jegasothy BV
    J Am Acad Dermatol; 1987 Jul; 17(1):40-52. PubMed ID: 2956298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas.
    Kvaløy S; Marton PF; Høst H; Solheim BG; Godal T
    Scand J Haematol; 1982 Apr; 28(4):293-305. PubMed ID: 6981200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies.
    van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ
    J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas.
    Schmoeckel C; Burg G; Braun-Falco O
    Arch Dermatol Res; 1979 Nov; 266(3):239-251. PubMed ID: 316689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
    Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
    Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B- and T-cell subsets in follicular centroblastic/centrocytic (cleaved follicular center cell) lymphoma: an immunohistologic analysis of 26 lymph nodes and three spleens.
    Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
    Hum Pathol; 1985 Apr; 16(4):339-52. PubMed ID: 2579888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalophil histiocytes in non-Hodgkin's lymphomas particularly in malignant proliferations of B-lymphocytes.
    Van Unnik JA; De Weger RA
    J Pathol; 1984 Dec; 144(4):241-51. PubMed ID: 6084055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.